Iain Ronald Gibson

Epidarex Capital Partners LLC (Epidarex Capital) is a venture capital firm founded in 2010 by Kyparissia Sirinakisvin. The firm is headquartered in Bethesda, Maryland.

MASA Life Science Ventures (MASA Life Science Venture) is a venture capital firm founded in 1994 by Andrew Sinclair Dunlop. The firm is headquartered in Bethesda, Maryland.

FTEN, Inc. provides financial technology solutions to financial institutions. It offers solutions to clearing firms, broker dealers, prime brokers, hedge funds, and proprietary traders. The company was founded by Ted Myerson in 2001 and is headquartered in New York City, NY.

Maryland Momentum Fund seeks investment opportunities in companies located in the United States. The fund targets companies operating in the fields of technology services and industries. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 1,50,000 to USD 5,00,000. It also makes follow-on investments.

CIT GAP Funds invests in companies located in United States, primarily in Virginia. The fund target companies operating in the fields of life sciences, hardware, software, biotechnology and agricultural sectors. It provides financing for seed and early stage requirements with an investment up to USD 0.125 million.

Virginia Innovation Partnership Corporation (Virginia Innovation Partnership) is a private equity/venture capital non-profit operating division of the Virginia Innovation Partnership Authority firm founded in 1985. The firm is headquartered in Herndon, Virginia.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Baxter, Inc. engages in the wholesale of medical, precision and scientific instruments. The company was founded on March 21, 1991 and is headquartered in Seoul, South Korea.

Orthox Ltd. develops tissue regenerative implants. The firm?s products include FibroFix Meniscus and FibroFix Cartilage. The company was founded by Nicholas James Vavasour Skaer and Oliver Kessler in 2008 and is headquartered in Abingdon, the United Kingdom.

Part of Smith & Nephew plc, Additive Instruments Ltd. is a British company that develops orthopedic surgical tools. The company is based in Watford, UK. Additive Instruments was acquired by Smith & Nephew UK Ltd. on March 09, 2023 for $11.84 million. The company was founded in 2019.

Epsilogen Ltd. engages in the development of immunoglobulin E (IgE) antibodies to treat cancer. The firm offers IGEG platform technology based on combining the power of IgE and Immunoglobulin G (IgG) antibody molecules. The company was founded by Sophia Karagiannis and James Spicer and is headquartered in London, United Kingdom.

Harpoon Medical, Inc. develops surgical services. It offers an image-guided, minimally invasive surgical tool for mitral valve repair that enables surgeons to access and repair the mitral valve in a beating heart via a small incision between the ribs without the need for cardiac arrest or cardiopulmonary bypass. The company was founded by James S. Gammie and Peter Wilson in July 2013 and is headquartered in Baltimore, MD.

Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019.

enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.

Center for Strategic & International Studies, Inc. provides strategic insights & policy solutions to decision makers in government, international institutions, the private sector, and civil society. Its projects focus on areas such as AIDS, arms control, conflict resolution, NATO, the environment, immigration, intelligence, trade, health care, OPEC, space policy, and terrorism. The company was founded in 1962 by David M. Abshire and Admiral Arleigh Burke and is headquartered in Washington, DC.

New Vantage Group LLC (New Vantage Group) is a venture capital firm founded in 1997 by John A. May. The firm is headquartered in McLean, Virginia.

Edinburgh Molecular Imaging Ltd. develops optical molecular imaging technology, which includes optical imaging, cancer imaging and lung imaging. The firm's molecular imaging technology, based on Fluorescent Imaging, has the potential to detect disease in real-time during interventional procedures including surgery, providing more accurate treatment while sparing healthy tissue. The company was founded by Chris Haslett, Kev Dhaliwal and Mark Bradley in February 2014 and is headquartered in Edinburgh, the United Kingdom.

Reform Scotland Ltd. operates as a charity firm. It promotes economic prosperity and public services based on the principles of limited government, diversity and personal responsibility. The firm publishes Reports, Briefings Fact Sheets and Scottish Government Trackers. The company was founded in 2008 and is headquartered in Edinburgh, the United Kingdom.

Inspiring Scotland engages in dealing and solving social problems for its people and communities. The company was founded by Helen Chambers in 2008 and is headquartered in Scotland, the United Kingdom.

Mironid Ltd. develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins. The company was founded by Miles Houslay, Paul Barton Rodgers, Elizabeth Fairley, Julia Adam, David Adams and Nigel Pyne in 2014 and is headquartered in North Lanarkshire, the United Kingdom.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.